Pharmafile Logo

Time and Cost Savings with Virtual Medical Education – Perks of Virtual Medical Education

Step into the future of medical education with significant time and cost savings! Virtual learning allows healthcare professionals to engage in training without travel, cutting costs and conserving valuable work hours. See how this approach benefits both learners and employers in our latest video!

Explore the significant time and cost benefits of virtual medical education in our seventh video from the “Perks of Virtual Medical Education” series. Learn why virtual learning is more than just convenient—it’s economically advantageous for both healthcare professionals and their employers.

7. Time and Cost-Savings The shift to virtual medical education offers substantial time and cost savings over traditional in-person training and learning sessions. Lengthy courses not only detract from employees’ productivity but also consume business hours and escalate budget spending, often without assured improvements in learning outcomes. Virtual events allow healthcare professionals to engage in educational activities on their own schedule, eliminating travel costs and reducing time away from work. This flexibility is greatly valued in the post-COVID era, as it allows both learners and their employers to better manage resources while still ensuring high-quality education and accreditation.

For more insights into the benefits of virtual collaboration and medical education, visit our blog: https://www.impetusdigital.com/2020/09/17/top-10-reasons-why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/

Enhance your virtual engagements with Impetus Digital:

Stay connected for the latest in efficient medical education:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

Versatility! Top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal...

New Playbook Alert: Virtual Patient Engagement

Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive...